Multicenter Analysis of Early Childhood Outcomes Following Repair of Truncus Arteriosus by Buckley, Jason R. et al.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Multicenter Analysis of Early Childhood Outcomes Following Repair of Truncus 
Arteriosus 
Running Head: Truncus Arteriosus Outcomes 
1Jason R. Buckley, MD; 2Venu Amula, MD; 3Peter Sassalos, MD; 4John M. Costello, MD, MPH; 
5Arthur J. Smerling, MD; 6lias Iliopoulos, MD; 7Aimee Jennings, PNP-AC/PC; 8Christine M. Riley, 
CPNP-AC; 9Katherine Cashen, DO; 10Sukumar Suguna Narasimhulu, MD, MPH; 11Keshava 
Murthy Narayana Gowda, MBBS; 12Adnan M. Bakar, MD; 13Michael Wilhelm, MD; 14Aditya 
Badheka, MD;  15Elizabeth AS Moser, MS; 16Christopher W. Mastropietro, MD; and the 
Collaborative Research in Pediatric Cardiac Intensive Care (CoRe-PCIC) Investigators. 
1 Department of Pediatrics, Medical University of South Carolina Children's Hospital, Charleston, 
SC 
2
 Department of Pediatrics, University of Utah School of Medicine, Primary Children's Hospital, 
Salt Lake City, UT 
3
 Department of Cardiac Surgery, University of Michigan, C.S. Mott Children's Hospital, Ann 
Arbor, MI 
4
 Department of Pediatrics, Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern 
University Feinberg School of Medicine 
5 Department of Pediatrics, Columbia University College of Physicians & Surgeons, Morgan 
Stanley Children's Hospital of New York, New York, NY 
6 Department of Pediatrics, The Heart Institute, Cincinnati Children's Hospital Medical Center, 
Cincinnati, OH 
7
 Department of Pediatrics, Seattle Children’s Hospital, Seattle, WA 
8
 Department of Pediatrics, Children's National Health System, Washington, DC 
9 Department of Pediatrics, Wayne State University School of Medicine, Children’s Hospital of 
Michigan, Detroit, MI 
10
 Department of Pediatrics, University of Central Florida College of Medicine, The Heart Center 
at Arnold Palmer Hospital for Children, Orlando, FL 
11 Department of Pediatrics, Cleveland Clinic, Cleveland, OH 
12
 Department of Pediatrics, Zucker School of Medicine at Hofstra / Northwell, Cohen Children's 
Medical Center of NY, New Hyde Park, NY 
13 Department of Pediatrics, University of Wisconsin, Madison, WI 
14 Department of Pediatrics, University of Iowa Stead Family Children's Hospital, Iowa City, IA 
15
 Department of Biostatistics, Indiana University School of Medicine & Richard M. Fairbanks 
School of Public Health, Indianapolis, IN 
16
 Department of Pediatrics, Indiana University School of Medicine, Riley Hospital for Children, 
Indianapolis, IN 
Classifications: congenital heart disease, truncus arteriosus, outcomes, pediatric 
___________________________________________________________________
This is the author's manuscript of the article published in final edited form as:
Buckley, J. R., Amula, V., Sassalos, P., Costello, J. M., Smerling, A. J., Iliopoulos, lias, … Mastropietro, C. W. (2018). 
Multicenter Analysis of Early Childhood Outcomes Following Repair of Truncus Arteriosus. The Annals of Thoracic 
Surgery. https://doi.org/10.1016/j.athoracsur.2018.08.094
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
Truncus Arteriosus Outcomes 
2 
Corresponding Author: 
Jason R. Buckley, MD 
Medical University of South Carolina 
601 Children’s Hospital 
165 Ashley Avenue, MSC 915 
Charleston, SC, 29425 
Email: buckleyj@musc.edu 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
  Truncus Arteriosus Outcomes 
3 
 
Abstract 
Background: Literature describing morbidity and mortality following truncus arteriosus repair is 
predominated by single-center reports. We created and analyzed a multicenter dataset to 
identify risk factors for late mortality and right ventricle-to-pulmonary artery (RV-PA) conduit 
reintervention for this patient population. 
Methods: We retrospectively collected data on children who underwent repair of truncus 
arteriosus without concomitant arch obstruction at 15 centers between 2009 and 2016. Cox 
regression survival analysis was conducted to determine risk factors for late mortality, defined 
as death occurring after hospital discharge and greater than 30 days after surgery. Probability of 
any RV-PA conduit reintervention was analyzed over time using Fine-Gray modelling.   
Results: We reviewed 216 patients, with median follow-up of 2.9 years (range:0.1-8.8). 
Operative mortaility occurred in 15 patients (7%). Of the 201 survivors, there were 14 (7%) late 
deaths. DiGeorge syndrome (HR:5.4; 95%CI:1.6-17.8) and need for postoperative tracheostomy 
(HR:5.9; 95%CI:1.8-19.4) were identified as independent risk factors for late mortality.  At least 
one RV-PA conduit catheterization or surgical reintervention was performed in 109 patients 
(median time to reintervention:23 months, range:0.3-93). Risk factors for reintervention included 
use of pulmonary or aortic homografts versus Contegra® bovine jugular vein conduits (HR:1.9; 
95%CI:1.2,3.1) and smaller conduit size (HR per mm/m2:1.05; 95%CI:1.03,1.08).  
Conclusions: In a multicenter dataset, DiGeorge syndrome and need for tracheostomy 
postoperatively were found to be independent risk factors for late mortality after repair of truncus 
arteriosus, while risk of conduit reintervention was independently influenced by both initial 
conduit type and size. 
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Truncus arteriosus is an uncommon, complex cardiac anomaly that continues to be 
associated with significant morbidity and mortality beyond the initial surgical repair. In single-
center studies with follow-up periods ranging from 2-24 years, mortality beyond the initial 
surgical hospitalization has been reported to be 2%-15%, while reintervention on the right 
ventricle to pulmonary artery (RV-PA) conduit later in life is nearly universal and the major 
source of long-term morbidity.[1-12]  While these single-center studies have provided valuable 
contributions to the literature, they are confounded by center specific surgical and perioperative 
management strategies, small sample sizes, and data that span different surgical eras 
To our knowledge, no multicenter data examining intermediate or long-term outcomes  
following surgical repair of truncus arteriosus have been published.  These data could facilitate 
risk factor delineation for poor outcome and target high-risk subgroups that deserve increased 
surveillance beyond the operative period.  We therefore aimed use a multicenter dataset to 
describe early childhood outcomes and determine risk factors for RV-PA conduit reintervention 
in children who have undergone truncus arteriosus repair in the contemporary era of neonatal 
repair.    
 
Patients and Methods 
Study Population 
We retrospectively collected data for children who underwent repair of truncus arteriosus 
from 2009-2016 at 15 tertiary care referral centers within the United States.  A list of 
participating institutions is provided in Supplemental Table 1. The study was approved by the 
institutional review boards at all participating centers and was performed in accordance with the 
ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Due to 
the retrospective nature of the data collected, the need for informed consent was waived.   
All patients with truncus arteriosus who underwent initial cardiac repair during the study 
period were considered for inclusion.  Patients with the following criteria were excluded from 
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analysis: 1) those who underwent pulmonary artery banding but died prior to repair; 2) diagnosis 
of hemitruncus or pseudotruncus; or 3) infants who underwent concomitant repair of truncus 
arteriosus with interrupted aortic arch or aortic arch obstruction (Van Praagh Type A4).  
Separate analysis of patients with the latter combination of lesions will be reported by this 
collaboration elsewhere. 
 
Data Collection and Definitions 
Baseline characteristics, operative data, and postoperative variables associated with the 
initial surgical repair were collected for all patients.  For operative mortality, we used the current 
STS-CHSD definition.[13]  Data were collected on the occurrence of mortality or RV-PA conduit 
reinterventions following hospital discharge after the initial surgical repair.  Late mortality was 
defined as mortality after hospital discharge and beyond 30 days of the initial surgical repair.  
Reintervention was defined as any cardiac catheterization or surgical procedure directed at the 
RV-PA conduit after the initial surgical repair, which included interventions performed prior to 
hospital discharge.  Data on late mortality and reinterventions after the initial surgical operation 
were collected on all patients from the time of their surgery to their last documented follow-up 
appointment. 
  
Statistical Analysis   
Data are represented using descriptive statistics, medians with 25th and 75th percentiles 
for continuous variables and absolute counts with percentages for categorical variables unless 
otherwise noted.  Characteristics of patients who suffered late mortality were compared to 
patients who survived the initial surgery using Wilcoxon rank-sum, Chi-squared, or Fisher’s 
Exact tests as appropriate for individual variables.  A multivariable Cox regression analysis was 
conducted to determine risk factors for late mortality.  Patients who suffered operative mortality 
were not included in these analyses.   
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RV-PA conduits were stratified into categories by indexed conduit diameter and 
compared using Kaplan-Meier survival analysis.  For patients with pulmonary, aortic, and 
Contegra® RV-PA conduit types, conduit characteristics, follow-up durations, and performance 
and timing of conduit reinterventions were compared using Chi-squared, Fisher’s Exact, or 
Kruskal-Wallis tests as appropriate.  The probability of any RV-PA conduit reintervention was 
performed using Fine-Gray modelling, which analyzed this outcome over time in the presence of 
the competing risk of mortality.[14]  All statistical analyses were performed using STATA version 
14 and SAS version 9.4. 
 
Results 
We reviewed 216 patients. Median follow-up was 2.9 years (range: 0.1−8.8).  Baseline 
characteristics and descriptive data from the initial surgical hospitalization are provided in 
Supplemental Table 2. Genetic testing for 22q.11 deletion was performed in 207 (96%) patients, 
and 61 (29%) patients were diagnosed with DiGeorge syndrome. Median age at surgery was 10 
days (25%,75%: 7,23).  Thirty-seven patients (17%) underwent concomitant truncal valve 
surgery.  Postoperative extracorporeal membrane oxygenation (ECMO) was utilized in 10% of 
the cohort. Operative mortality was 7% (n=15). 
Kaplan-Meier survival analysis for all patients is depicted in Figure 1.  Of the 201 
patients who survived their initial surgical repair, there were 14 late deaths (7%) occurring at a 
median of 8.3 months (range: 2.5−77.9) after the initial surgery. Ten of the 14 (71%) late deaths 
occurred within the first 12 months after surgery.  Bivariate comparison of patients who died 
after hospital discharge and those who survived is provided in Tables 1 and 2.  DiGeorge 
syndrome, preoperative mechanical ventilation, performance of an unplanned reoperation 
excluding postoperative bleeding, and tracheostomy were significantly more common in patients 
who suffered late mortality, while center volume, concomitant truncal valve surgery at the initial 
repair and residual truncal valve insufficiency were not associated with late mortality.  Using Cox 
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Regression analysis, DiGeorge syndrome and tracheostomy at discharge were identified as 
independent risk factors for late mortality (Table 3).  Further details on the events leading to late 
mortalities are provided in Supplemental Table 3. 
One hundred nine patients (50%) underwent at least one RV-PA conduit catheter or 
surgical reintervention.  Median time to first conduit reintervention was 23 months (range: 
0.3−93) after initial surgery.  Initial conduit intervention was balloon angioplasty in 19 cases, 
balloon angioplasty with stent placement in 30 cases, placement of a vascular plug for a conduit 
pseudoaneurysm in one patient, conduit patch in one patient, and replacement in 58 cases.   
The relationship between conduit size and need for conduit reintervention is illustrated in Figure 
2.  Patients with smaller conduit diameters placed at their initial surgical repair were more likely 
to require reintervention during the study follow-up period as compared to patients with larger 
conduit diameters. 
Pulmonary homografts, aortic homografts or Contegra® bovine jugular vein conduits 
were used for the overwhelming majority (n=191, 88%) of the study population, of which 102 
(53%) underwent conduit reintervention.  Additional data relevant to patients with one of these 
conduit types, including the frequency of conduit reinterventions and surgical conduit 
replacements, are provided in Table 4.  Duration of follow-up for patients with each of the three 
conduit types was statistically similar, but fewer reinterventions were noted in Contegra® bovine 
jugular vein conduits.  Additionally, three cases of endocarditis occurred in our cohort, all of 
which were due to staphylococcus infection.  Two cases occurred in patients that received an 
aortic homograft and one occurred in a patient with a Contegra® conduit. 
Probability of any RV-PA conduit reintervention (e.g., catheter or surgical) or surgical 
replacement are illustrated in Figure 3 and Supplemental Figure 1, respectively.  Probability of 
conduit reintervention was not statistically different between pulmonary and aortic conduits.  
Probability of conduit reintervention in pulmonary or aortic conduits at any time point 
postoperatively however, was significantly greater than that of Contegra® conduits, independent 
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of conduit diameter.  Independent risk factors for RV-PA conduit intervention included the use of 
pulmonary or aortic homografts and smaller conduit diameter (indexed to body surface area).  
Specifically, for every 1 mm/m2 decrease in RV-PA conduit size, the risk of reintervention 
increased by 5% (p<0.001; Table 5).  Similar to our findings regarding late mortality, center 
volume was not significantly associated with need for RV-PA conduit intervention. 
 
Comment 
To our knowledge, this study represents the first multicenter analysis of early childhood 
outcomes following repair of truncus arteriosus.  In our cohort, 14 of the 201 hospital survivors 
died in the follow-up period.  Importantly, the majority (71%) of these deaths occurred within the 
first year after surgery, a finding that is mirrored by several single-center studies examining 
outcomes after surgical repair of truncus arteriosus.[1,2,4,10,12,15] 
 Risk factors for late mortality reported in other studies include severe truncal valve 
insufficiency, truncal valve replacement, and low weight (≤ 2.5 kg) at the time of initial 
repair.[3,4,12]  These single-center studies included patients who underwent surgery over 
multiple decades; thus, an “era effect” may have influenced the findings relative to those who 
underwent surgery during the contemporary era.  We identified two independent risk factors for 
late mortality: DiGeorge syndrome and need for postoperative tracheostomy.  Three of 61 
patients with DiGeorge syndrome had operative mortality while an additional 10 patients 
suffered late death, resulting in an overall and late mortality rate of 21% and 17%, respectively.  
In a single-center retrospective study of 171 patients with truncus arteriosus conducted by 
Naimo and colleagues, DiGeorge syndrome was also found to be an independent risk factor for 
late mortality.[12]  Unfortunately, further understanding regarding the association between 
DiGeorge syndrome and late mortality is hindered by the absence of clear explanations for 
many of the late deaths in our study, which frequently occurred unexpectedly at home or outside 
hospitals. 
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  The need for tracheostomy after congenital heart surgery has been associated with poor 
long-term outcomes in several studies, especially in patients with complex lesions.[16,17] In our 
analysis, two of twelve patients with tracheostomies died prior to hospital discharge and five 
suffered late mortality.  Data regarding the indications for tracheostomy and details regarding 
airway anatomy and bronchoscopic findings were not collected, thus making it impossible to 
determine whether residual cardiac lesions, non-cardiac comorbidities, or a complication related 
to the tracheostomy itself was the primary cause of death.   
Late mortality rates of 17% and 50% for patients with DiGeorge syndrome and 
tracheostomy, respectively, rival and exceed those observed in patients with hypoplastic left 
heart syndrome during the interstage period, prior to the widespread adoption of home 
monitoring.[18]  The attention applied to improving interstage mortality in this fragile patient 
population has led to notable successes via improved surveillance and coordination of care after 
hospital discharge.[19]  Multidisciplinary DiGeorge syndrome follow-up clinics and provision of 
coordinated post-discharge care could ensure optimal management of non-cardiac 
comorbidities. Centers should also ensure that their pediatric home ventilation program is in 
accord with current guidelines.[20]  We hypothesize that increased surveillance of high-risk 
patients with truncus arteriosus could potentially prevent some late deaths with modest 
additional resource utilization, given the relatively small number of such patients treated at 
individual centers. 
We identified RV-PA conduit size was an independent risk factor for both conduit 
reintervention and surgical replacement, which is in accord with previous work.[3-5,21,22]  
Specifically, conduit diameters less than 45 mm/m2 had the greatest risk of early conduit 
reintervention.  The use of larger conduits aimed at affording patients some degree of freedom 
from reintervention seems intuitive, but this benefit needs to be reconciled with the possibility 
that larger conduit size may predispose to greater short-term risk of morbidity and mortality.  In 
a prior analysis of our cohort, we found conduit diameter greater than 50 mm/m2 to be an 
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independent risk factor for major adverse cardiac events (e.g. cardiopulmonary resuscitation, 
ECMO, or mortality) in the operative period.[23]  Based on these data, 45-50 mm/m2 may 
represent the conduit diameter range that optimally balances the risk of morbidity and mortality 
in the immediate postoperative period and long-term complications.  Further study should be 
pursued to confirm these findings.  Most importantly, though later and possibly fewer 
interventions and reoperations are unquestionably desirable, survival after initial repair is 
paramount and supersedes any efforts to extend the longevity of conduit.  Moreover, operative 
mortality after subsequent RV-PA conduit replacement has been reported to be 0% in numerous 
contemporary single-center studies.[7,8,21,22] 
We also determined that Contegra® bovine jugular vein conduits had significantly lower 
probability of reintervention than aortic or pulmonary homografts, independent of conduit 
diameter.  This difference was primarily related to differences in the number of cardiac 
catheterization interventions undertaken in patients with Contegra® conduits as compared to 
patients with aortic or pulmonary homografts.  These findings contrast with several published 
single-center reports that have attempted to compare the durability of different conduit types, 
most commonly presented as Kaplan-Meier “conduit survival” analyses or actuarial freedom 
from reintervention analyses.[4,5,7,8,15,21,22].  These analytical approaches assume that 
patients who are censored would continue to be at risk of failure events after censorship, which 
is not the case when patients die prior to conduit intervention.  We sought to eliminate this 
limitation by determining the probability of RV-PA conduit intervention while accounting for the 
competing risk of mortality.  This more rigorous analysis and the multicenter nature of the data, 
two characteristics which we deem to be strengths of this study, may account for the differences 
in our findings compared to prior published studies.   
This study is limited by its retrospective design.  For example, although surviving 
patients were censored at latest follow-up, data on late mortality or conduit reintervention and 
replacement for patients who moved or had care transferred to a different institution may not 
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have been available and, as a result, occurrence rates for these events may be underestimated.    
Additionally, echocardiographic or anthropometric data beyond the initial surgical admission was 
not collected, limiting our ability to assess the potential impact of cardiac performance or 
somatic growth on outcomes and reinterventions. Lastly, the indication for RV-PA conduit 
reinterventions and reoperations were not clear in the medical record for most patients and, 
importantly, likely vary across centers.  Accordingly, though we did not find a relationship 
between center volume and outcomes, it is difficult to disregard a possible overall effect of 
center on RV-PA conduit reintervention and late mortality from our analyses. 
 
Conclusions 
This study represents the first multicenter analysis of early childhood outcomes following 
repair of truncus arteriosus.  Late mortality remains significant in the contemporary era and 
predominates during the first year after surgical repair.  Increased surveillance after hospital 
discharge for high-risk subpopulations should therefore be considered.  Further, use of 
Contegra® bovine jugular vein RV-PA conduits or conduits with larger diameters may be less 
likely to require early reintervention, though more study is warranted to determine optimal size 
and composition of RV-PA conduits to extend conduit longevity without increasing the risk of 
early morbidity and mortality.    
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Table 1. Comparison of Patients with and without Late Mortality after Repair of Truncus Arteriosus – 
Demographic information and Baseline Patient Characteristics 
Variable a Survived (n=187) Late Mortality (n=14) p-value 
Truncus Type (Van Praagh) 
 A1 
 A2 
 A3 
 
98 (52%) 
76 (41%) 
13 (7%) 
 
10 (71%) 
3 (21%) 
1 (7%) 
0.28 
 
Prematurity (<37 weeks) 33 (18%) 5 (36%) 0.15 
Female sex 94 (50%) 7 (50%) 0.98 
Chromosomal anomaly, any  69 (37%) 10 (71%) 0.01 
 DiGeorge/22q.11 deletion  48 (26%) 10 (71%) 0.001 
Non-cardiac anatomic anomaly  53 (28%) 6 (43%) 0.36 
Prenatal diagnosis 115 (62%) 10 (71%) 0.46 
Age at diagnosis (days) 0 (0,2) 0 (0,1) 0.59 
Diagnosed before discharge from nursery 147 (79%) 11 (79%) 1.00 
Preoperative shock 17 (9%) 2 (14%) 0.63 
Preoperative mechanical ventilation 32 (17%) 8 (57%) 0.002 
Preoperative infection 24 (13%) 2 (14%) 0.70 
Year of surgical repair 
 2009 - 2012 
 2013 - 2016  
 
90 (48%) 
97 (52%) 
 
6 (43%) 
8 (57%) 
0.70 
Center Volume 
 < 1 operation / year 
 ≥ 1 < 2 operations / year 
 ≥ 2 < 3 operations / year 
 ≥ 3 operations / year 
 
15 (8%) 
20 (11%) 
103 (55%) 
49 (26%) 
 
1 (7%) 
4 (29%) 
4 (29%) 
5 (36%) 
0.09 
 
a Continuous variables represented as median (25th%, 75th%); categorical data represented as absolute counts (%) 
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Table 2.  Comparison of Patients with and without Late Mortality after Repair of Truncus Arteriosus – Data 
from Initial Surgical Repair 
Variable a Survived (n=187) Late Mortality (n=14) p-value 
Age at surgery (days) 10 (7, 25) 7 (6, 14) 0.12 
Weight at surgery (kg) 3.1 (2.7, 3.6) 2.8 (2.5, 3.8) 0.46 
CPB duration (min) 146 (123, 182) 143 (137, 209) 0.47 
Hypothermic circulatory arrest  27 (14%) 4 (29%) 0.24 
RV-PA conduit type 
 Aortic allograft 
 Pulmonary allograft 
 Contegra® conduit 
 Other / None 
 
47 (25%) 
72 (39%) 
47 (25%) 
21 (11%) 
 
3 (21%) 
6 (43%) 
2 (14%) 
3 (21%) 
0.58 
RV-PA conduit size (mm/m2)  51 (45, 55) 51 (46, 59) 0.51 
Truncal valve anatomy 
 Bicuspid 
 Tricuspid 
 Quadricuspid 
 Dysplastic 
 
23 (12%) 
100 (54%) 
62 (34%) 
2 (1%) 
 
3 (21%) 
7 (50%) 
4 (29%) 
0 (0%) 
0.58 
 
Coronary artery abnormality 25 (13%) 0 (0%) 0.14 
Truncal valve repaired  27 (14%) 4 (29%) 0.24 
Truncal valve replaced  3 (2%) 1 (7%) 0.25 
Residual truncal valve insufficiency 
             Mild 
Mild-to-moderate 
Moderate 
             Moderate-to-severe 
95 (51%) 
62 
15 
17 
1 
8 (57%) 
5 
2 
1 
0 
0.81 
 
Delayed sternal closure 101 (54%) 11 (79%) 0.07 
Postoperative ECMO 11 (6%) 3 (21%) 0.06 
Inhaled nitric oxide 86 (46%) 6 (43%) 0.82 
Unplanned cardiac catherization  17 (9%) 3 (21%) 0.15 
Unplanned reoperation - bleeding 10 (5%) 2 (14%) 0.20 
Unplanned reoperation - not bleeding 15 (8%) 4 (29%) 0.03 
Tracheostomy prior to discharge 5 (3%) 5 (36%) <0.001 
CPB: cardiopulmonary bypass; RV-PA: right ventricle-to-pulmonary artery; ECMO: extracorporeal membrane 
oxygenation. Continuous data presented as median (25th%,75th%); categorical data presented as absolute counts (%) 
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Table 3. Cox Multivariable Regression Analysis: Risk Factors for Late Mortality 
Variable Hazard Ratio (95% Confidence Interval)  p-value 
DiGeorge syndrome 5.4 (1.6, 17.8) 0.006 
Tracheostomy  5.9 (1.8, 19.4) 0.003 
Postoperative ECMO 3.5 (0.9, 13.8) 0.07 
ECMO, extracorporeal membrane oxygenation. 
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Table 4. RV-PA Conduit Characteristics and Outcomes 
Variable a 
Pulmonary 
Homograft       
(n = 83) 
Aortic 
Homograft       
(n = 53) 
Contegra®      
(n= 55) 
p-value 
Conduit size, mm 10 (9, 11) 9 (9, 11) 12 (12, 12) <0.001 
Conduit size, mm/m2 50 (44, 54) 49 (46, 55) 54 (48, 58) 0.01 
Duration of follow-up, months 36 (18, 60) 36 (22, 63) 42 (15, 77) 0.51 
Patients with reinterventions b  48 (58%) 33 (62%) 21 (38%) 0.02 
     Time to first reintervention b, months 12 (6, 23) 13 (5, 27) 20 (10, 43) 0.28 
Patients with surgical replacements 39 (47%) 25 (47%) 19 (35%) 0.29 
     Time to first replacement, months 23 (8, 37) 26 (11, 31) 20 (11, 55) 0.72 
RV-PA, right ventricle-to-pulmonary artery. 
a Continuous variables represented as median (25th%, 75th%); categorical data represented as absolute counts (%) 
b Reintervention defined as any cardiac catheterization or surgical procedure directed at the RV-PA conduit after   the 
initial surgical repair, including interventions performed prior to hospital discharge 
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Table 5. Multivariable Logistic Regression Analysis of Factors Impacting RV-PA Conduit Durability 
Variable Hazard Ratio 
95% Confidence 
Interval p-value 
Probability of Any RV-PA Conduit Intervention    
     Pulmonary/Aortic vs. Contegra® 1.9 1.2, 3.1 < 0.01 
     Indexed Conduit Size (mm/m2) 1.05 1.02, 1.08 < 0.01 
Probability of RV-PA Conduit® Surgical Replacement    
     Pulmonary/Aortic vs. Contegra® 1.6 0.96, 2.7 0.07 
     Indexed Conduit Size (mm/m2) 1.05 1.02, 1.08 < 0.01 
RV-PA: right ventricle to pulmonary artery 
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Figure Legends 
 
Figure 1. Kaplan-Meier Survival Curve after Repair of Truncus Arteriosus. Number at risk are 
provided at each twelve month time point, with number of mortalities during each time interval 
provided in parentheses.  There were 29 deaths, 14 of which were late deaths. The majority 
(n=10, 71%) of the late mortality occurred within the first 12 months after surgical repair. 
 
Figure 2.  Kaplan-Meier curve demonstrating the relationship between conduit size and need for 
conduit intervention. Need for intervention over time appears to increase as conduit diameter 
decreases (log-rank p-value < 0.001).  Note: Nine patients who did not have conduits placed 
(i.e. 8 direct anastomoses, 1 systemic-to-pulmonary artery shunt) at the initial surgery are not 
included.       
 
Figure 3. Probability of RV-PA Conduit Intervention. Contegra® bovine jugular vein conduits 
(green) had a lower probability of intervention compared with pulmonary (blue) and aortic (red) 
homografts, accounting for the competing risk of mortality over time (p=0.02). 
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